Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
18,215,532
-
Share change
-
+4,950,073
-
Total reported value
-
$67,216,000
-
Put/Call ratio
-
61%
-
Price per share
-
$3.69
-
Number of holders
-
35
-
Value change
-
+$21,271,488
-
Number of buys
-
19
-
Number of sells
-
13
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) as of Q4 2017
As of 31 Dec 2017,
SUNESIS PHARMACEUTICALS INC - COM PAR (SNSS) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,215,532 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Balyasny Asset Management LLC, BVF INC/IL, Boxer Capital, LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, Vanguard Group Inc, DAFNA Capital Management LLC, and BAKER BROS. ADVISORS LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.